We envision a world where every cancer patient has access to the best possible minds, therapies and innovations in care - in time to make a difference.
Anju Mathew is CEO and co-founder of OncoLens. Most recently...
Lijo is a board certified Hematologist and Medical Oncologist with
Eric is a recognized technologist with substantial software..
Mustaqeem Siddiqui, MD, MBA is a practicing Hematologist/Oncologist and Assistant Professor at the Mayo Clinic, and is immersed in developing new technologies, products, and services in patient care. Mustaqeem is currently a Medical Director in Mayo’s Global Business Solutions business unit, where he supports New Product Development. In addition, he is a member of the Rochester Area Economic Development Inc. (RAEDI) Economic Development Fund, and Mayo Clinic Treasury’s Venture Co-Investment Committee. Mustaqeem previously led venture formation and business development at Mayo’s Center for Innovation.
He completed his residency in Internal Medicine and Fellowship in Hematology and Oncology at the Mayo Clinic. He earned his MBA from the University of Chicago Booth School of Business, and his passions include entrepreneurship in healthcare, transforming healthcare delivery, and Formula One.
Jane is Assistant Director at ATDC. Jane returned to ATDC as a Startup Catalyst, having started her career here many years ago. She then moved into venture capital and investment banking both in the United States and Europe before joining an early-stage, medical diagnostics company as chief financial officer. During her time there, she raised $60 million and completed eight international acquisitions. The company was listed on both the London and Oslo stock exchanges.
Jane then worked with two venture-backed companies. She joined the founders of an online travel company as CEO, and took it from startup to the world’s second-largest hotel booking site before Travelocity acquired it. At the request of her venture investors, Jane then joined a computer games developer as CEO and turned around the faltering enterprise before it was sold to a NASDAQ-listed games company.
Most recently, Jane was CEO of an oncology-focused clinical research company, which grew from startup to a multinational firm with $15 million in annual revenue and offices across Europe and the United States. The company was financed through its own cash flow and was sold in early 2012 to a larger clinical research organization.
Jane continues to work with fast growing companies — in interim and full-time positions — as a consultant, board member, and angel investor. In addition, Jane has served on boards for public and private companies, as well as government-related and non-profit organizations. She is a frequent speaker and panelist at conferences, companies, and universities and is an active volunteer in her community. Jane obtained her bachelor’s degree from Wake Forest University and her master’s degree at the Georgia Institute of Technology.